Clinical management of community acquired pneumonia in the elderly patient

Author

Cillóniz, Catia

Ceccato, Adrian

San Jose, Alicia

Torres Martí, Antoni

Publication date

2019-11-12T14:32:41Z

2019-11-12T14:32:41Z

2016-10-03

2019-11-12T14:32:41Z

Abstract

Introduction: Community acquired pneumonia (CAP) is a major health problem in elderly persons and is associated with high morbidity and mortality. Areas covered: This article reviews the most recent publications relative to CAP in the elderly population, with a focus on epidemiology, prognostic factors, microbial etiology, therapy and prevention. The data discussed in this review were mainly obtained from a non-systematic review using Medline, and references from relevant articles. Expert commentary: CAP can occur at any age, but its incidence and risk of death are linked to increasing age. Age-related changes in the immune system make this population more vulnerable to CAP. Mortality in hospitalized patients with CAP ranges from 10% to 12%. However, in the case of elderly patients, several studies have reported mortality rates of up to 25%. Pneumococcal and influenza vaccination comprise one of the most important preventive approaches for CAP in the elderly.

Document Type

Article
Accepted version

Language

English

Subjects and keywords

Pneumònia adquirida a la comunitat; Persones grans; Community-acquired pneumonia; Older people

Publisher

Taylor and Francis

Related items

Versió postprint del document publicat a: https://doi.org/10.1080/17476348.2016.1240037

Expert Review Of Respiratory Medicine, 2016, vol. 10, num. 11, p. 1211-1220

https://doi.org/10.1080/17476348.2016.1240037

Rights

(c) Taylor and Francis, 2016